Technical Analysis for MLND - Millendo Therapeutics, Inc.

Grade Last Price % Change Price Change
F 0.993 -4.06% -0.04
MLND closed down 4.17 percent on Thursday, April 15, 2021, on 63 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical MLND trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish -3.86%
Narrow Range Bar Range Contraction -3.86%
New 52 Week Low Weakness -3.86%
Wide Bands Range Expansion -3.86%
Oversold Stochastic Weakness -3.86%
Narrow Range Bar Range Contraction -7.87%
Wide Bands Range Expansion -7.87%
Oversold Stochastic Weakness -7.87%
New 52 Week Closing Low Bearish -6.13%
Narrow Range Bar Range Contraction -6.13%
Older End-of-Day Signals for MLND ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
3x Volume Pace about 3 hours ago
2x Volume Pace about 3 hours ago
1.5x Volume Pace about 3 hours ago
Down 5% about 3 hours ago
Down 3% about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Millendo Therapeutics is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases where current therapies do not exist or are insufficient. The Company’s objective is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of endocrine diseases where there is a significant unmet medical need. The Company is currently advancing livoletide for the treatment of Prader-Willi syndrome and nevanimibe for the treatment of classic congenital adrenal hyperplasia and endogenous Cushing’s syndrome.

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Endocrine System Hyperplasia Late Stage Biopharmaceutical Cushing's Syndrome Adrenal Gland Disorders Congenital Adrenal Hyperplasia Endocrine Disease Classic Congenital Adrenal Hyperplasia Endocrine Diseases

Is MLND a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 3.62
52 Week Low 1.025
Average Volume 886,375
200-Day Moving Average 1.82
50-Day Moving Average 1.98
20-Day Moving Average 1.55
10-Day Moving Average 1.16
Average True Range 0.14
ADX 40.54
+DI 10.97
-DI 40.74
Chandelier Exit (Long, 3 ATRs ) 1.99
Chandelier Exit (Short, 3 ATRs ) 1.43
Upper Bollinger Band 2.55
Lower Bollinger Band 0.55
Percent B (%b) 0.24
BandWidth 129.10
MACD Line -0.28
MACD Signal Line -0.25
MACD Histogram -0.0337
Fundamentals Value
Market Cap 19.66 Million
Num Shares 19 Million
EPS -4.87
Price-to-Earnings (P/E) Ratio -0.21
Price-to-Sales 0.00
Price-to-Book 0.84
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.13
Resistance 3 (R3) 1.14 1.12 1.12
Resistance 2 (R2) 1.12 1.09 1.11 1.11
Resistance 1 (R1) 1.08 1.07 1.06 1.07 1.11
Pivot Point 1.05 1.05 1.04 1.05 1.05
Support 1 (S1) 1.01 1.03 1.00 1.00 0.96
Support 2 (S2) 0.99 1.01 0.98 0.96
Support 3 (S3) 0.95 0.99 0.95
Support 4 (S4) 0.94